|
3561 |
|
Year: 2022 Vol. 26 Num. 2 - Apr/June - (12º)
DOI: 10.1055/s-0042-1743274
|
|
|
Section:
Original Article
|
|
|
|
|
Incidence of Olfactory and Gustatory Dysfunctions in the Early Stages of COVID-19: An Objective Evaluation |
|
Author(s): |
Monica Manhas, Disha Koul, Gopika Kalsotra, Amit Manhas, Parmod Kalsotra, Parmil Kumar, Abid Bhat, Anchal Gupta, Aditya Saraf
|
|
|
Key words: |
COVID-19 - SARS-CoV-2 - anosmia - ageusia - olfactory and gustatory dysfunction (OGD) |
|
|
|
Abstract: |
Introduction Coronavirus disease 2019 (COVID-19) is a dangerous infectious disease caused by a newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has various clinical presentations. Numerable cases with non-specific olfactory and gustatory dysfunctions in COVID-19 have been reported from all over the globe. This is important as awareness will let people to self-isolate and help in limiting disease spread.
Objective To objectively evaluate the frequency of olfactory and gustatory dysfunction, which may occur independently or with other symptoms, in laboratory confirmed COVID-19 patients at an early stage of the disease.
Methods Objective evaluation of olfactory and gustatory function of 322 COVID-19 patients treated at our hospital, (SMGS, Government Medical College, Jammu), from August 2020 until November 2020.
Results Our study population included 127 (39.4%) males and 195 (60.6%) females. Two hundred and twenty-six (70.2%) COVID-19 patients experienced olfactory and gustatory disorders. One hundred and sixty-five (51.2%) cases experienced both olfactory and gustatory disorders. Isolated olfactory dysfunction was reported in 34 (10.6%) patients, while 27 (8.4%) patients experienced only gustatory dysfunction.
Conclusion The olfactory and gustatory dysfunctions, without any nasal obstruction or rhinorrhea, are significant symptoms in the clinical presentation of early COVID-19 patients. This presentation can be recognized at the earliest one, and it can reduce the high communicability of the COVID-19 disease.
|
|
|
|
|
|
|
|